 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 June 1996 | Volume 124 Issue 12 | Pages 1061-1064
Background: Successful outcomes after cardiopulmonary resuscitation remain disappointingly infrequent. In animal studies, administration of exogenous vasopressin during closed- and open-chest cardiopulmonary resuscitation has recently been shown to be more effective than optimal doses of epinephrine in improving vital organ blood flow.
Objective: To describe the clinical effects and outcomes of administering vasopressin to patients in cardiac arrest refractory to current medical therapies.
Design: Case reports.
Setting: University hospital.
Patients: 8 adults with in-hospital cardiac arrest.
Interventions: After intravenous epinephrine (administered according to American Heart Association guidelines) and defibrillation efforts had failed, patients in cardiac arrest who were having cardiopulmonary resuscitation received 40 U of vasopressin intravenously and then defibrillation.
Measurements: Return of spontaneous circulation and hospital discharge rates.
Results: After administration of vasopressin, spontaneous circulation was promptly restored in all patients. Three patients were discharged from the hospital with intact neurologic function; the other five lived for between 30 minutes and 82 hours.
Conclusion: In the presence of ventricular fibrillation with severe hypoxia and acidosis, vasopressin seems to be more potent and effective than adrenergic vasopressors for restoring spontaneous cardiovascular function. These results do not justify the widespread use of vasopressin for refractory cardiac arrest. However, on the basis of these cases, further studies comparing vasopressin with epinephrine are warranted in an effort to improve the currently dismal prognosis of patients after cardiac arrest.
Author and Article Information
From the University of Ulm, Ulm, Germany, and the University of Minnesota, Minneapolis, Minnesota.
BRIEF COMMUNICATION
Vasopressin Administration in Refractory Cardiac Arrest
Grant Support: In part by a grant from the Laerdal Foundation, Oslo, Norway.
Requests for Reprints: Keith Lurie, MD, Cardiac Arrhythmia Center, University of Minnesota Medical School, Box 508 UMHC, 420 Delaware Street Southeast, Minneapolis, MN 55455.
Current Author Addresses: Drs. Lindner, Prengel, Brinkmann, Strohmenger, and Lindner: Universitatsklinik fur Anasthesiologie, Klinikum der Universitat Ulm, Steinhovelstrasse 9, 89075 Ulm (Donau), Germany.
This article has been cited by other articles:
|
|
 |
|
  D Papadimitriou, T Xanthos, I Dontas, P Lelovas, and D Perrea The use of mice and rats as animal models for cardiopulmonary resuscitation research Lab Anim, July 1, 2008; 42(3): 265 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kumazawa, H. Iida, M. Uchida, M. Iida, M. Takenaka, N. Fukuoka, T. Michino, and S. Dohi The Effects of Transient Cerebral Ischemia on Vasopressin-Induced Vasoconstriction in Rabbit Cerebral Vessels Anesth. Analg., March 1, 2008; 106(3): 910 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.M. Smith, C.M. Elliot, D.G. Kiely, and K.S. Channer The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension QJM, March 1, 2006; 99(3): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Part 7.2: Management of Cardiac Arrest Circulation, December 13, 2005; 112(24_suppl): IV-58 - IV-66. [Full Text] [PDF]
|
|
|
|
|
|
Part 4: Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Heath, D. Hanson, R. Long, and N. A. Crowell Critical Care Providers' Perceptions of the Use of Vasopressin in Cardiac Arrest Am. J. Crit. Care., November 1, 2005; 14(6): 481 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L Koshman, P. J Zed, and R. B Abu-Laban Vasopressin in Cardiac Arrest Ann. Pharmacother., October 1, 2005; 39(10): 1687 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Stadlbauer, V. Wenzel, A. C. Krismer, W. G. Voelckel, and K. H. Lindner Vasopressin During Uncontrolled Hemorrhagic Shock: Less Bleeding Below the Diaphragm, More Perfusion Above Anesth. Analg., September 1, 2005; 101(3): 830 - 832. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Aung and T. Htay Vasopressin for Cardiac Arrest: A Systematic Review and Meta-analysis Arch Intern Med, January 10, 2005; 165(1): 17 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Dyke II and J. D. Tobias Vasopressin: Applications in Clinical Practice J Intensive Care Med, July 1, 2004; 19(4): 220 - 228. [Abstract] [PDF]
|
|
|
|
 |
|
 T E Locker, K Hogg, R Mahu, and I Crawford Vasopressin or adrenaline in cardiac resuscitation * Authors' reply Emerg. Med. J., July 1, 2004; 21(4): 522 - 522. [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Williams, A. Y. Denault, M. Pellerin, and R. Martineau Vasopressin for treatment of shock following aprotinin administration: [Traitement a la vasopressine pour un choc suivant l'administration d'aprotinine] Can J Anesth, February 1, 2004; 51(2): 169 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Wenzel, A. C. Krismer, H. R. Arntz, H. Sitter, K. H. Stadlbauer, K. H. Lindner, and the European Resuscitation Council Vasopressor dur A Comparison of Vasopressin and Epinephrine for Out-of-Hospital Cardiopulmonary Resuscitation N. Engl. J. Med., January 8, 2004; 350(2): 105 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cao, M. H. Weil, S. Sun, and W. Tang Vasopressor Agents for Cardiopulmonary Resuscitation Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 115 - 121. [Abstract] [PDF]
|
|
|
|
|
|
K. H. Stadlbauer, H. G. Wagner-Berger, V. Wenzel, W. G. Voelckel, A. C. Krismer, G. Klima, K. Rheinberger, S. Pechlaner, V. D. Mayr, and K. H. Lindner Survival with Full Neurologic Recovery After Prolonged Cardiopulmonary Resuscitation with a Combination of Vasopressin and Epinephrine in Pigs Anesth. Analg., June 1, 2003; 96(6): 1743 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. D. Mayr, V. Wenzel, W. G. Voelckel, A. C. Krismer, T. Mueller, K. G. Lurie, and K. H. Lindner Developing a Vasopressor Combination in a Pig Model of Adult Asphyxial Cardiac Arrest Circulation, October 2, 2001; 104(14): 1651 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Landry and J. A. Oliver The Pathogenesis of Vasodilatory Shock N. Engl. J. Med., August 23, 2001; 345(8): 588 - 595. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Wenzel and K. H. Lindner Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor Cardiovasc Res, August 15, 2001; 51(3): 529 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Krismer, K. H. Lindner, V. Wenzel, V. D. Mayr, W. G. Voelckel, K. G. Lurie, and H. U. Strohmenger The Effects of Endogenous and Exogenous Vasopressin During Experimental Cardiopulmonary Resuscitation Anesth. Analg., June 1, 2001; 92(6): 1499 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. DiGregorio Pharmacotherapeutic Advances in Cardiac Resuscitation: A Review of the Advanced Cardiac Life Support (ACLS) 2000 Guidelines and Their Impact on Pharmacy Practice Journal of Pharmacy Practice, February 1, 2001; 14(1): 41 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 V. Wenzel, K. H. Lindner, A. C. Krismer, W. G. Voelckel, M. F. Schocke, W. Hund, M. Witkiewicz, E. A. Miller, G.u. Klima, J.o. Wissel, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs J. Am. Coll. Cardiol., February 1, 2000; 35(2): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L.S. Morales, D. Gregg, D. N. Helman, M. R. Williams, Y. Naka, D. W. Landry, and M. C. Oz Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock Ann. Thorac. Surg., January 1, 2000; 69(1): 102 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Krismer, K. H. Lindner, R. Kornberger, V. Wenzel, G. Mueller, W. Hund, S. Oroszy, K. G. Lurie, and P. Mair Cardiopulmonary Resuscitation During Severe Hypothermia in Pigs: Does Epinephrine or Vasopressin Increase Coronary Perfusion Pressure? Anesth. Analg., January 1, 2000; 90(1): 69 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Voelckel, K. H. Lindner, V. Wenzel, J. O. Bonatti, A. C. Krismer, E. A. Miller, and K. G. Lurie Effect of Small-Dose Dopamine on Mesenteric Blood Flow and Renal Function in a Pig Model of Cardiopulmonary Resuscitation with Vasopressin Anesth. Analg., December 1, 1999; 89(6): 1430 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Rosenzweig, T. J. Starc, J. M. Chen, S. Cullinane, D. M. Timchak, W. M. Gersony, D. W. Landry, and M. E. Galantowicz Intravenous Arginine-Vasopressin in Children With Vasodilatory Shock After Cardiac Surgery Circulation, November 9, 1999; 100(90002): II-182 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Wenzel, K. H. Lindner, A. C. Krismer, E. A. Miller, W. G. Voelckel, and W. Lingnau Repeated Administration of Vasopressin but Not Epinephrine Maintains Coronary Perfusion Pressure After Early and Late Administration During Prolonged Cardiopulmonary Resuscitation in Pigs Circulation, March 16, 1999; 99(10): 1379 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Gueugniaud, P. Mols, P. Goldstein, E. Pham, P.-Y. Dubien, C. Deweerdt, M. Vergnion, P. Petit, P. Carli, and The European Epinephrine Study Group A Comparison of Repeated High Doses and Repeated Standard Doses of Epinephrine for Cardiac Arrest Outside the Hospital N. Engl. J. Med., November 26, 1998; 339(22): 1595 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Wenzel, K. H. Lindner, S. Augenstein, A. W. Prengel, H. U. Strohmenger, and R. C. Koehler Vasopressin Combined With Epinephrine Decreases Cerebral Perfusion Compared With Vasopressin Alone During Cardiopulmonary Resuscitation in Pigs • Editorial Comment Stroke, July 1, 1998; 29(7): 1462 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Advanced Life Support Working Group of the Europea The 1998 European Resuscitation Council guidelines for adult advanced life support BMJ, June 20, 1998; 316(7148): 1863 - 1869. [Full Text]
|
|
|
|
|
|
S. S. Chugh, K. G. Lurie, and K. H. Lindner Pressor With Promise : Using Vasopressin in Cardiopulmonary Arrest Circulation, October 7, 1997; 96(7): 2453 - 2454. [Full Text]
|
|
|
|
|
|
K. A Ballew Recent advances: Cardiopulmonary resuscitation BMJ, May 17, 1997; 314(7092): 1462 - 1462. [Full Text]
|
|
Article
